158 related articles for article (PubMed ID: 33370966)
21. A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor.
Faria AM; Perez RV; Marcondes JA; Freire DS; Blasbalg R; Soares J; Simões K; Hayashida SA; Pereira MA
Nat Rev Endocrinol; 2011 Apr; 7(4):240-5. PubMed ID: 21321567
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series.
Fanta M; Fischerová D; Indrielle-Kelly T; Koliba P; Zdeňková A; Burgetová A; Vrbíková J
J Obstet Gynaecol; 2019 Apr; 39(3):359-364. PubMed ID: 30428740
[TBL] [Abstract][Full Text] [Related]
23. Hilus cell pathology and hirsutism.
McLellan AR; Mowat A; Cordiner J; Beastall GH; Wallace AM; Connell JM; Davies DL
Clin Endocrinol (Oxf); 1990 Feb; 32(2):203-12. PubMed ID: 2112066
[TBL] [Abstract][Full Text] [Related]
24. Ovarian hilus-cell tumours: their varying presentations.
Salm R
J Pathol; 1974 Jun; 113(2):117-27. PubMed ID: 4371065
[No Abstract] [Full Text] [Related]
25. A rare ovarian Leydig cell tumor (hilar type) causing virilization in a postmenopausal woman.
Vouza E; Kairi-Vassilatou E; Kleanthis CK; Hasiakos N; Salakos N; Kondi-Pafiti A
Eur J Gynaecol Oncol; 2011; 32(5):557-9. PubMed ID: 22053675
[TBL] [Abstract][Full Text] [Related]
26. Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.
Sanz OA; Martinez PR; Guarch RT; Goñi MJ; Alcazar JL
Maturitas; 2007 Jun; 57(2):214-6. PubMed ID: 17289310
[TBL] [Abstract][Full Text] [Related]
27. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
Souto SB; Baptista PV; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
[TBL] [Abstract][Full Text] [Related]
28. Pure leydig cell tumour of the ovary in a post-menopausal patient with severe hyperandrogenism and erythrocytosis.
Yetkin DO; Demirsoy ET; Kadioglu P
Gynecol Endocrinol; 2011 Apr; 27(4):237-40. PubMed ID: 20518640
[TBL] [Abstract][Full Text] [Related]
29. [Virilizing ovarian tumor: a rare cause of androgenetic alopecia].
Bahloul E; Amouri M; Masmoudi A; Chaabene K; Mnif F; Makni S; Amouri H; Abid M; Boudawara T; Turki H
Ann Dermatol Venereol; 2015 Apr; 142(4):303-4. PubMed ID: 25813185
[No Abstract] [Full Text] [Related]
30. Virilising ovarian tumour: a case associating a Sertoli-Leydig cell tumour and a Brenner tumour.
Persechini ML; Motton S; Leguevaque P; Donadille F; Escourrou G; Vierasu B; Hamdi S; Bennet A; Caron P
Gynecol Endocrinol; 2011 May; 27(5):345-50. PubMed ID: 20569103
[TBL] [Abstract][Full Text] [Related]
31. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours.
Pascale MM; Pugeat M; Roberts M; Rousset H; Déchaud H; Dutrieux-Berger N; Tourniaire J
Clin Endocrinol (Oxf); 1994 Nov; 41(5):571-6. PubMed ID: 7828344
[TBL] [Abstract][Full Text] [Related]
32. Bilateral virilizing hilus (Leydig) cell tumors of the ovary.
Duun S
Acta Obstet Gynecol Scand; 1994 Jan; 73(1):76-7. PubMed ID: 8304034
[TBL] [Abstract][Full Text] [Related]
33. Hyperandrogenism in post-menopausal women: a diagnosis challenge.
Tutzer M; Winnykamien I; Davila Guardia J; Castelo-Branco C
Gynecol Endocrinol; 2014 Jan; 30(1):23-5. PubMed ID: 24188447
[TBL] [Abstract][Full Text] [Related]
34. Ovarian Leydig Cell Tumor: Cause of Virilization in a Postmenopausal Woman.
Mourinho Bala N; Aragüés JM; Guerra S; Brito D; Valadas C
Am J Case Rep; 2021 Aug; 22():e933126. PubMed ID: 34449760
[TBL] [Abstract][Full Text] [Related]
35. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
Mai PL; Miller A; Black A; Falk RT; Boggess JF; Tucker K; Stuckey AR; Rodriguez GC; Wong C; Amatruda TT; Wilkinson KJ; Modesitt SC; Yamada SD; Bixel KL; Glaser GE; Rose PG; Greene MH; Sherman ME
Am J Obstet Gynecol; 2022 Jul; 227(1):61.e1-61.e18. PubMed ID: 35216968
[TBL] [Abstract][Full Text] [Related]
36. [A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary].
Marcelino M; Nobre E; Conceição J; Lopes L; Vilar H; França Martins M; Carvalho A; André S; Horta A; De Castro JJ
Acta Med Port; 2010; 23(1):113-8. PubMed ID: 20353714
[TBL] [Abstract][Full Text] [Related]
37. Hyperandrogenism caused by ovarian Leydig cell tumour: finding the needle in a haystack.
Tong CV; Tai YT
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33318251
[TBL] [Abstract][Full Text] [Related]
38. Hyperandrogenism due to ovarian Leydig cell tumour presenting with polycythaemia.
Demir AY; Blok BB; Brinkhuis EA; Oldenburg-Ligtenberg CP
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35840164
[TBL] [Abstract][Full Text] [Related]
39. Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.
Palha A; Cortez L; Tavares AP; Agapito A
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27803082
[TBL] [Abstract][Full Text] [Related]
40. [Stromal leydig cell tumor coexisting with ascites].
Czupkałło G; Jakowicki JA; Baranowski W
Ginekol Pol; 2001 Oct; 72(10):825-8. PubMed ID: 11848020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
